Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price was down 16.7% on Thursday . The company traded as low as GBX 2.30 ($0.03) and last traded at GBX 2.30 ($0.03). Approximately 288,265 shares were traded during trading, an increase of 81% from the average daily volume of 159,581 shares. The stock had previously closed at GBX 2.76 ($0.04).
Proteome Sciences Trading Down 5.1 %
The firm has a market capitalization of £7.73 million, a PE ratio of -262.00 and a beta of 0.07. The firm has a 50 day simple moving average of GBX 3.01 and a 200 day simple moving average of GBX 3.38.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Read More
- Five stocks we like better than Proteome Sciences
- Business Services Stocks Investing
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Investing in Commodities: What Are They? How to Invest in Them
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Compound Interest and Why It Matters When Investing
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
